Webinar Event

Comparative Effectiveness: Implications for Plans, Providers and Other Stakeholders

• Review of the current state of comparative effectiveness research in U.S. health care
• Different models of comparative effectiveness used in developed health systems.
• Key lessons from abroad that demonstrate the complexity of implementation in the U.S.
• Implementation Realities including the status of applicable health reform initiatives

Overview

Generating better evidence about the costs and benefits of different treatment options – through research on the comparative effectiveness of those options – has the potential to bend the curve in health care spending and reduce inappropriate variation in the system.

Join Paul Keckley, Executive Director of the Deloitte Center for Health Solutions, Deloitte LLP, in an examination of comparative effectiveness implications for a variety of stakeholders, including policy makers, providers, consumers, payors/health plans, and life sciences companies, based upon the recent Deloitte Center for Health Solutions study: "Comparative Effectiveness: Perspectives for Consideration." Report findings conclude that, in the U.S., a “tools, not rules” approach, with industry and policy makers working side by side, will result in a comparative effectiveness model that delivers better value and lower costs.
 

Learning Objectives

• Review of the current state of comparative effectiveness research in U.S. health care
• Examination of different models of comparative effectiveness used in developed health systems.
• Discussion of key lessons from abroad that demonstrate the complexity of implementation in the U.S.
• Realities of implementing comparative effectiveness in the U.S., including the status of health reform efforts to advance comparative effectiveness.
• Implications for plans, providers, life science organizations and government.
• How better evidence about the costs and benefits of different treatment options can help reduce health-care spending without adversely affecting health.

Who Should Attend

• C-Suite Executives
• Medical Directors
• Care Management Executives and Staff
• Policy Executives and Staff
• Strategy and Planning Executives and Staff
• Health Care Analytics Executives
• Other Interested Parties

Attendees would represent organizations including

• Health Plans
• Hospitals
• Life Science Organizations
• Medical Groups
• Provider Networks
• Employers
• Third Party Administrators
• PBMs
• Care Management Organizations
• Solutions Providers
• Associations, Institutes and Research Organizations
• State and Local Government
• Media